Dernières nouvelles
- Ernst, MélanieEmployéCHUL+1 418-525-4444, poste 47044Melanie.Ernst@crchudequebec.ulaval.ca
2705, boulevard Laurier
A-1602
Québec, Québec
Canada G1V 4G2 - Giannakouros, PanagiotaEmployéCHUL+1 418-525-4444, poste 40192Panagiota.Giannak@crchudequebec.ulaval.ca
2705 Boulevard Laurier
A-0121
Québec, QC
Canada G1V 4G2
Survival Following Tumor Recurrence in Children With Medulloblastoma
Article de revueJ Pediatr Hematol Oncol, 40 (3), 2018.
Trametinib for progressive pediatric low-grade gliomas
Article de revueJ Neurooncol, 140 (2), 2018.
Sustained complete response of recurrent glioblastoma to combined checkpoint inhibition in a young patient with constitutional mismatch repair deficiency
Article de revuePediatr Blood Cancer, 65 (12), 2018.
Comprehensive Analysis of Hypermutation in Human Cancer
Article de revueCell, 171 (5), 2017.
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
Article de revueJ Clin Oncol, 35 (25), 2017.
Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature
Article de revueJ Neurooncol, 132 (1), 2017.
Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study
Article de revueJ Clin Oncol, 34 (29), 2016.
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Article de revueJ Clin Oncol, 34 (19), 2016.
Rare Presentation of Supratentorial Primitive Neuroectodermal Tumors Mimicking Bifocal Germ Cell Tumors: 2 Case Reports
Article de revueJ Pediatr Hematol Oncol, 38 (2), 2016.
Low grade astrocytoma in children under the age of three years: a report from the Canadian pediatric brain tumour consortium
Article de revueJ Neurooncol, 124 (1), 2015.
Projets actifs
- Analyse de la cohorte de neuro-oncologie pédiatrique, du 2024-04-01 au 2027-03-31
- Phase III randomized double-blind placebo-controlled trial of metformin for cognitive recovery and white matter growth in paediatric medulloblastoma patients, du 2022-06-21 au 2027-12-25
Projets terminés récemment
- A Phase 2 study of Trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathwa, du 2019-04-01 au 2024-09-30
- Subvention pour la recherche clinique, du 2008-04-01 au 2024-03-31